English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/149365
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Integral characterization of defective BDNF/TrkB signalling in neurological and psychiatric disorders leads the way to new therapies

AuthorsTejeda, Gonzalo S.; Díaz-Guerra, Margarita
Issue Date28-Jan-2017
PublisherMultidisciplinary Digital Publishing Institute
CitationInternational Journal of Molecular Sciences 18(2): 268 (2017)
AbstractEnhancement of brain-derived neurotrophic factor (BDNF) signalling has great potential in therapy for neurological and psychiatric disorders. This neurotrophin not only attenuates cell death but also promotes neuronal plasticity and function. However, an important challenge to this approach is the persistence of aberrant neurotrophic signalling due to a defective function of the BDNF high-affinity receptor, tropomyosin-related kinase B (TrkB), or downstream effectors. Such changes have been already described in several disorders, but their importance as pathological mechanisms has been frequently underestimated. This review highlights the relevance of an integrative characterization of aberrant BDNF/TrkB pathways for the rational design of therapies that by combining BDNF and TrkB targets could efficiently promote neurotrophic signalling.
Publisher version (URL)https://doi.org/10.3390/ijms18020268
URIhttp://hdl.handle.net/10261/149365
DOI10.3390/ijms18020268
ISSN1661-6596
Identifiersdoi: 10.3390/ijms18020268
Appears in Collections:(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
ijms-18-00268-v2.pdf1,75 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.